Sermorelin 10mg Peptides
Precision begins with uncompromising materials, and this vial is engineered for consistent, reproducible research outcomes.
Primavora Sermorelin is a 10mg lyophilized peptide vial designed for controlled laboratory use. Presented as a stable, freeze-dried powder, this single-ingredient preparation supports investigators seeking reliable consistency and clear data integrity in growth hormone axis research models.
- Each vial contains 10mg of Sermorelin, a growth hormone-releasing hormone analog used in laboratory settings to investigate receptor signaling, pituitary pathways, and assay-dependent responses under strictly controlled conditions.
The lyophilized format offers convenient handling in research environments. The peptide reconstitutes cleanly for precise aliquoting and methodical experimental design, supporting work that demands accurate concentrations and repeatable protocols. This format helps maintain molecular integrity during storage and transit, aligning with studies that prioritize stability, traceability, and dependable batch-to-batch performance.
Every lot is produced in the USA under stringent quality controls and is supported by documented specifications. Identity and purity are assessed using validated analytical methods appropriate to peptides (e.g., HPLC/LC-MS), with tight acceptance criteria to help ensure consistency. Vials are sealed to protect against contamination and light exposure, then lot-coded for traceability within regulated laboratory workflows. Researchers can expect a clean presentation, clear labeling, and dependable documentation to support audit-ready recordkeeping.
Use is intended strictly for qualified professionals in laboratory environments. Follow institutional protocols for reconstitution, handling, and disposal. Store as directed to preserve integrity, avoid repeated freeze-thaw cycles once reconstituted, and maintain aseptic technique where applicable. This product is not formulated, packaged, or labeled for human or veterinary use and should never be administered to humans or animals. It is supplied for research use only.
Primavora focuses on purity, consistency, and transparency. Our commitment to careful sourcing, controlled manufacturing, and rigorous verification reflects a simple standard: quality first. For laboratories that require dependable peptide materials and clear documentation, Sermorelin 10mg provides a professional, research-ready option backed by meticulous processes and a disciplined approach to product stewardship.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Sermorelin typically studied for?
Researchers usually study Sermorelin for pulsatile growth-hormone release, pituitary responsiveness, and downstream GH/IGF-1 signaling. A good FAQ can also explain that it is generally shorter-acting than some modified GHRH analogs, which is why it is often compared with CJC-1295-based products.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.